Results 31 to 40 of about 633,595 (269)

Susceptibility to Hepatitis A and B Virus Among Clients at a Syringe Services Program in Philadelphia, 2018. [PDF]

Public Health Rep, 2020
Objectives Although many people who use drugs meet criteria for vaccination against hepatitis A virus (HAV) and hepatitis B virus (HBV), estimates of susceptibility (ie, lack of immunity) are not well established.
Figgatt M, Hildick-Smith J, Addish E, Coleman J, Benitez J, Freeland C, Alles S, Viner K, Johnson C, Kuncio D.   +9 more
europepmc   +2 more sources

Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL. [PDF]

Harm Reduct J, 2020
Background Blood-borne viral infections, such as HIV and hepatitis C (HCV), are common infections among people who inject drugs (PWID). This study aims to determine the prevalence of HIV and HCV infection among PWID accessing the first legal syringe ...
Bartholomew TS, Onugha J, Bullock C, Scaramutti C, Patel H, Forrest DW, Feaster DJ, Tookes HE.   +7 more
europepmc   +2 more sources

Perspectives on hepatitis A and B screening and immunization at a syringe services program: a mixed-methods study [PDF]

Harm Reduction Journal
Background People who inject drugs (PWID) are at increased risk for viral hepatitis, yet hepatitis A virus (HAV) and hepatitis B virus (HBV) screening and immunization rates remain low. Although offering HAV and HBV services at syringe services programs (
Subul Malik, Marina Plesons, Monica Faraldo, Tyler S. Bartholomew, Hansel E. Tookes, Edward Suarez, David W. Forrest   +6 more
doaj   +2 more sources

The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015. [PDF]

Public Health Rep, 2020
Objectives The impact of a syringe services program (SSP) policy on risk behaviors and its durability are not as well studied as the impact of the SSPs themselves.
Nassau T, Al-Tayyib A, Robinson WT, Shinefeld J, Brady KA.   +4 more
europepmc   +2 more sources

Perspectives of syringe services program operators in Michigan on their relationship with substance use treatment: a qualitative study [PDF]

Harm Reduction Journal
Background Substance use treatment (SUT) and harm reduction are often perceived as having distinct goals despite people who use drugs routinely having needs that encompass both services.
Molly C. Reid, Samantha J. Harris, Suzanne M. Grieb, Sabrina Gattine, Zekiye Lukco, Brandon Hool, Mary Aguirre, Fernanda Alonso Aranda, Catherine Tomko, Sara Whaley, Brendan Saloner, Sean T. Allen   +11 more
doaj   +2 more sources

Estimated cost of comprehensive syringe service program in the United States.

PLoS ONE, 2019
ObjectiveTo estimate the cost of establishing and operating a comprehensive syringe service program (SSP) free to clients in the United States.MethodsWe identified the major cost components of a comprehensive SSP: (one-time start-up cost, and annual ...
Eyasu H Teshale, Alice Asher, Maria V Aslam, Ryan Augustine, Eliana Duncan, Alyson Rose-Wood, John Ward, Jonathan Mermin, Kwame Owusu-Edusei, Patricia M Dietz   +9 more
doaj   +3 more sources

Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives. [PDF]

Int J Drug Policy, 2022
Austin EJ, Corcorran MA, Briggs ES, Frost MC, Behrends CN, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Jarlais DCD, Williams EC, Glick SN.   +15 more
europepmc   +2 more sources

Racial differences in overdose training, naloxone possession, and naloxone administration among clients and nonclients of a syringe services program. [PDF]

J Subst Abuse Treat, 2021
Jones AA, Park JN, Allen ST, Schneider KE, Weir BW, Hunt D, Sherman SG.   +6 more
europepmc   +2 more sources

Adverse childhood experiences, resilience, and syringe services program attendance among persons who inject drugs in Northeast Georgia, USA: A mediation analysis. [PDF]

Drug Alcohol Depend Rep
Haider MR, Clinton S, Brown MJ, Hansen NB.   +3 more
europepmc   +2 more sources

Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida. [PDF]

J Subst Abuse Treat, 2021
Bartholomew TS, Feaster DJ, Patel H, Forrest DW, Tookes HE.   +4 more
europepmc   +2 more sources